江苏农业学报
江囌農業學報
강소농업학보
JIANGSU JOURNAL OF AGRICULTURAL SCIENCES
2009年
6期
1320-1324
,共5页
胡波%王芳%秦爱建%范志宇%徐为中%张则斌%薛家宾%何孔旺
鬍波%王芳%秦愛建%範誌宇%徐為中%張則斌%薛傢賓%何孔旺
호파%왕방%진애건%범지우%서위중%장칙빈%설가빈%하공왕
兔出血症病毒%重组腺病毒%表达%免疫原性
兔齣血癥病毒%重組腺病毒%錶達%免疫原性
토출혈증병독%중조선병독%표체%면역원성
rabbit hemorrhagic disease virus%recombinant adenovirus%expression%immunogenicity
通过RT-PCR方法扩增上海地区兔出血症病毒(RHDV)衣壳蛋白基因(VP60).将其克隆入腺病毒表达载体系统中,构建成重组腺病毒质粒,用脂质体法转染HEK293细胞,得到重组病毒pAd-VP60,经RT-PCR、IFA、HA、SDS-PAGE和Western-blotting鉴定,结果表明重组VP60蛋白在HEK293细胞中获得表达.表达产物与铝胶佐剂混合后注射3月龄非免疫健康家兔,结果表明,免疫后21 d兔体内产生抗RHDV抗体,其HI效价可达2~6~2~7,能抵御HA≥2~(10)致死剂量RHDV强毒的攻击,保护率为100%.
通過RT-PCR方法擴增上海地區兔齣血癥病毒(RHDV)衣殼蛋白基因(VP60).將其剋隆入腺病毒錶達載體繫統中,構建成重組腺病毒質粒,用脂質體法轉染HEK293細胞,得到重組病毒pAd-VP60,經RT-PCR、IFA、HA、SDS-PAGE和Western-blotting鑒定,結果錶明重組VP60蛋白在HEK293細胞中穫得錶達.錶達產物與鋁膠佐劑混閤後註射3月齡非免疫健康傢兔,結果錶明,免疫後21 d兔體內產生抗RHDV抗體,其HI效價可達2~6~2~7,能牴禦HA≥2~(10)緻死劑量RHDV彊毒的攻擊,保護率為100%.
통과RT-PCR방법확증상해지구토출혈증병독(RHDV)의각단백기인(VP60).장기극륭입선병독표체재체계통중,구건성중조선병독질립,용지질체법전염HEK293세포,득도중조병독pAd-VP60,경RT-PCR、IFA、HA、SDS-PAGE화Western-blotting감정,결과표명중조VP60단백재HEK293세포중획득표체.표체산물여려효좌제혼합후주사3월령비면역건강가토,결과표명,면역후21 d토체내산생항RHDV항체,기HI효개가체2~6~2~7,능저어HA≥2~(10)치사제량RHDV강독적공격,보호솔위100%.
The capsid protein VP60 gene of rabbit hemorrhagic disease virus was amplified by reverse transcript pol-ymerase chain reaction (RT-PCR) technique. The fragment was cloned into the system of adenovirus expression and trans-fected into HEK293 cells, and a recombinant adenovirus named pAd-VP60 was obtained. The expressed protein was identified by RT-PCR, IFA, HA, SDS-PAGE and Westeru-blotting. The recombinant protein of VP60 was expressed in HEK293 cells. The expressed protein was mixed with aluminum rubber adjuvant and applied to im-munize three-month-old rabbits without immunized RHD vaccine. The results indicated that the anti-RHDV antibod-ies were induced and developed after 21 d of immuniza-tion, with the HI titers of serum ranging from 2~6 to 2~7.When challenged with HA> 2~(10) units of infectious RHDV, the control rabbits died while the immunized animals all survived. The results suggested that the recombinant pro-teins expressed by recombinant adenovirus could be promising candidates for RHDV live vaccines.